» Articles » PMID: 31267978

Patient Attitudes and Their Awareness Towards Skin Cancer-Related Apps: Cross-Sectional Survey

Overview
Date 2019 Jul 4
PMID 31267978
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the emerging era of digitalization and electronic health, skin cancer-related apps represent useful tools to support dermatologic consultation and examination. Yet, little is known about how patients perceive the value of such apps.

Objective: The aim of this study was to investigate patient attitudes and their awareness toward skin cancer-related apps.

Methods: A cross-sectional study including 200 patients from the oncological outpatient unit was conducted at the University Hospital (LMU Munich, Germany) between September and December 2018. Patients were asked to complete a self-administered questionnaire on the popularity and usefulness of health-related and skin cancer-related apps. A descriptive analysis was performed with the expression of categorical variables as frequencies and percentages. For continuous variables, the median and range were indicated. Contingency tables and chi-square tests were performed to investigate associations between sociodemographic data and selected items of the questionnaire.

Results: A total of 98.9% (195/197) of patients had never used skin cancer-related apps or could not remember. In 49.7% (93/187) of cases, patients were unsure about the usefulness of skin cancer apps, whereas 42.6% (78/183) thought that skin cancer apps could supplement or support the professional skin examination performed by a physician. However, 47.9% (90/188) were interested in acquiring more information by their dermatologists about skin cancer apps. Young age (P=.002), male gender (P=.02), a previous history of melanoma (P=.004), and higher educational level (P=.002) were significantly associated with a positive attitude. Nevertheless, 55.9% (105/188) preferred a printed patient brochure on skin cancer to downloading and using an app.

Conclusions: The experience and knowledge of skin cancer-related apps was surprisingly low in this population, although there was a high general interest in more information about such apps. Printed patient brochures were the preferred information source.

Citing Articles

Digitisation and health: Second nationwide survey of internet users in Germany.

De Santis K, Muellmann S, Pan C, Hoffmann S, Spallek J, Haug U Digit Health. 2024; 10:20552076241301457.

PMID: 39600383 PMC: 11590152. DOI: 10.1177/20552076241301457.


Acceptance of Medical Artificial Intelligence in Skin Cancer Screening: Choice-Based Conjoint Survey.

Jagemann I, Wensing O, Stegemann M, Hirschfeld G JMIR Form Res. 2024; 8:e46402.

PMID: 38214959 PMC: 10818228. DOI: 10.2196/46402.


Opportunities to inform German residents about the possibility of skin cancer screening and to inform stakeholders to take appropriate actions: A qualitative approach.

Steeb T, Wessely A, Heppt M, Erdmann M, Klug S, Berking C Cancer Med. 2023; 12(9):10829-10839.

PMID: 37062065 PMC: 10225179. DOI: 10.1002/cam4.5717.


The Effects of Lack of Awareness in Age-Related Quality of Life, Coping with Stress, and Depression among Patients with Malignant Melanoma.

Toma A, Boeriu E, Decean L, Bloanca V, Bratosin F, Levai M Curr Oncol. 2023; 30(2):1516-1528.

PMID: 36826077 PMC: 9955948. DOI: 10.3390/curroncol30020116.


Prevalence and Age-Related Patterns in Health Information-Seeking Behaviors and Technology Use Among Skin Cancer Survivors: Survey Study.

Marchetti M, Sar-Graycar L, Dusza S, Nanda J, Kurtansky N, Rotemberg V JMIR Dermatol. 2023; 5(2):e36256.

PMID: 36776536 PMC: 9910806. DOI: 10.2196/36256.


References
1.
Kessel K, Vogel M, Kessel C, Bier H, Biedermann T, Friess H . Mobile Health in Oncology: A Patient Survey About App-Assisted Cancer Care. JMIR Mhealth Uhealth. 2017; 5(6):e81. PMC: 5489709. DOI: 10.2196/mhealth.7689. View

2.
Zimmer L, Apuri S, Eroglu Z, Kottschade L, Forschner A, Gutzmer R . Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. Eur J Cancer. 2017; 75:47-55. DOI: 10.1016/j.ejca.2017.01.009. View

3.
Brutting J, Bergmann M, Weber C, Berking C, Tilgen W, Schadendorf D . [Information services for melanoma patients and awareness among those affected]. Hautarzt. 2018; 69(4):335-339. DOI: 10.1007/s00105-018-4130-9. View

4.
Thissen M, Udrea A, Hacking M, von Braunmuehl T, Ruzicka T . mHealth App for Risk Assessment of Pigmented and Nonpigmented Skin Lesions-A Study on Sensitivity and Specificity in Detecting Malignancy. Telemed J E Health. 2017; 23(12):948-954. DOI: 10.1089/tmj.2016.0259. View

5.
Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D . Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017; 7(2):1-6. PMC: 5424654. DOI: 10.5826/dpc.0702a01. View